Treatment of testicular cancer - Is quality management possible?

Onkologie

Volumn 24, Issue 2, 2001, Pages 177-179

  Kohrmann K U ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

CANCER INCIDENCE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; LYMPHADENECTOMY; NOTE; ORGANIZATION; PATIENT CARE; PRODUCTIVITY; PROGNOSIS; SCIENTIFIC LITERATURE; TESTIS CANCER;

CLINICAL TRIALS; HUMANS; MALE; NEOPLASM STAGING; SURVIVAL RATE; TESTICULAR NEOPLASMS; TOTAL QUALITY MANAGEMENT; TREATMENT FAILURE;

EID: 0035036469     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050311     Document Type: Note

References (10)

1. Einhorn LH, Donohue JP Advanced tcslicular cancer. Update for Urologist. J Urol 1998;160: 1964-1969.
2. Clemm C, Sauer H, Schilling S, Binsack T, Willmanns W Rehabilitation von Patienten mit malignem Keimzelltumor. Versicherungsmedizin 1991;43:105.
3. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richards WS Evidence based medicine: What it is and what it isn't. BMJ 1996312:71-72.
4. Woolf SH Practice Guidelines, a new reality in medicine. Arch Intern Med 1992;152:946-952.
5. Weißbach L, Bamberg M, Schmoll HJ Interdisziplinäre Konsensuskonferenz zur Diagnostik und Therapie von Hodentumoren. Urologe A 1997;36: 362-368.
6. Collette L, Sylvester RJ, Stenning SP, Fossa SD, Mead GM, de Wit R, de Mulder PH, Neymark N, Lallemand E, Kaxe SB Impact of the treating institution on survival of patients with 'poor-prognosis' metastatic nonseminoma. European Organization for Research and Treatment of Cancer, Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. J Natl Cancer Inst 1999;91:839.
7. Köhrmann KU, Frede T, Martinez Portillo FJ, Alken P, Siegsmund M Häufigkeit und Ursache von Todesfällen bei Hodentumor-Patienlen: Eine retrospektive, unizentrische Analyse. Urologe A (submitted for publication).
8. Köhrmann KU, Albers P, Hartmann M, Heidenreich A, Krege S, Walz P, Weber A, Alken P Management analysis of patients who died of germ cell tumors. J Urol 1999;161(suppl):697.
9. Einhorn LH, Donohue J Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977;87:293-298.
10. Albers P, Kleinschmidt K: Ist der Hodentumor ein Modell? Urologe A 199S;37:591-592.